NCT06998771 2025-05-31JSKN003 Combined Treatment of HER2-positive Gastric CancerShanghai JMT-Bio Inc.Phase 2 Not yet recruiting153 enrolled
NCT06439550 2024-06-03Adjuvant Treatment With Serplulimab，Trastuzumab and SOX in the HER-2 Positive GC/GEJCThe First Affiliated Hospital of Zhengzhou UniversityPhase 2 Not yet recruiting42 enrolled